Mode
Text Size
Log in / Sign up
N/A Completed N=10 Diagnostic

Monitoring Medication Adherence in Left Ventricular Assist Device Recipients

Heart Failure · Medication Compliance
Source: ClinicalTrials.gov NCT02388386 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcomePrimary: System Performance - Positive Detection Accuracy — 80 percentage of ingestions

Summary

The investigators aim to develop a novel and wireless method for monitoring medication adherence among heart failure patients with left ventricular assist devices (LVADs). Proteus Digital™ has developed an ingestible and bio-absorbable micro-sensor as a strategy to monitor medication compliance. The edible sensor has at its core a silicon-based integrated circuit measuring 1.0 mm x 0.45 mm and is imbedded on a pill. Once ingested, this circuit is activated by gastric acid resulting in an electrochemical redox reaction and an electrical charge that is transmitted to a patch worn over the abdomen and wirelessly to a portable device such as a smart phone. This strategy of medication adherence differs from conventional adherence monitoring including pill counting and patient-recall by precisely tracking medication ingestion.

Outcome Measures

OutcomeResultp-value
PRIMARY
System Performance - Positive Detection Accuracy
80
SECONDARY
Number of Participants With Adverse Events as a Measure of Safety and Tolerability
0; 0; 0; 0

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing LVAD implantation for end-stage heart failure or admitted from the out-patient setting

Exclusion Criteria

  • Unable to consistently consume oral intake
  • Hemodynamic instability defined as hypotension requiring intravenous vasoactive medications or arrhythmias requiring intravenous antiarrhythmics or oral antiarrhythmics for rhythm stabilization
  • Gastrointestinal bleeding requiring intravenous gastric acid secretion inhibitors
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02388386). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search